Antibody to TRAF4, a TNF receptor-associated factor involved in various signaling pathways – altered expression can contribute to cancer development.
| Institute |
|---|
| Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) |
| Cat. #: | 162398 |
|---|---|
| Research Fields: | Cell signaling and signal transduction |
| Application: | ELISA, WB, IHC, ICC |
| Target: | TRAF4 / MLN62 |
| Reactivity: | Human, mouse |
| Clone: | TRAF-2H1 |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Régnier et al. (2002) Proc Natl Acad Sci U S A. 99(8):5585-90. PMID: 11943846 |
| Product description: | Antibody to TRAF4, a TNF receptor-associated factor involved in various signaling pathways – altered expression can contribute to cancer development. |
|---|---|
| Additional notes: | Avoid repeat freezing and thawing cycles. Does not contain any preservative. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1, k |
| Immunogen: | Synthetic peptide coupled to Ovalbumin (C-QSDPGLAKPQHVTETFHPD) corresponding to aa 393-411 of human TRAF4. |
| Target background: | TRAF4 is a TNF receptor-associated factor involved in various signaling pathways, and its altered expression can contribute to cancer development. |
|---|
| Storage conditions: | -20°C (up to 3 years) |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151017 | Anti-MBP [R29.6] |
Key Info
Anti-MBP [R29.6]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.